Stockscreener 앱 받기
0.1703
0.53%
-0.0009
시장 영업 전:
.17
-0.0003
-0.18%
Applied Dna Sciences Inc 주식(APDN)의 최신 뉴스
A History of Outperforming Analyst Forecasts and Beating the Odds: Applied Dna Sciences Inc (APDN) - SETE News
Breaking down APDN’s current quarter earnings estimates - US Post News
Applied DNA Sciences Announces Change in Certifying Accountant – Form 8-K Filing - Defense World
Applied DNA Sciences Appoints New Auditor By Investing.com - Investing.com South Africa
Applied DNA Sciences Appoints New Auditor - Investing.com
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health - ACCESS Newswire
Applied DNA Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Applied DNA Sciences Holds Special Meeting of Stockholders - Defense World
Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit - ACCESS Newswire
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - ACCESS Newswire
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - ACCESS Newswire
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress - ACCESS Newswire
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates - ACCESS Newswire
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out - ACCESS Newswire
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing - ACCESS Newswire
Applied DNA Sciences fails to secure shareholder vote - MSN
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 - ACCESS Newswire
Applied DNA Sciences fails to secure shareholder vote By Investing.com - Investing.com Australia
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - ACCESS Newswire
Applied DNA Launches Mpox Clade I and Clade II Testing Service - ACCESS Newswire
Applied DNA Announces 1-For-20 Reverse Stock Split - ACCESS Newswire
Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Drops By 5.1% - Defense World
73,396 Shares in Applied DNA Sciences, Inc. (NASDAQ:APDN) Purchased by Jane Street Group LLC - Defense World
Applied DNA Sciences Utilizes Company Presentation for Investor Outreach - Defense World
Applied DNA Sciences Advances in Genetic Medicines Market - TipRanks
APDNApplied DNA Sciences, Inc. Latest Stock News & Market Updates - StockTitan
Applied DNA Sciences Completes GMP Facility for mRNA Production, Eyes $30M Revenue Potential - StockTitan
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter - Weatherford Democrat
Applied DNA Sciences Reschedules Q1 2025 Earnings Call and Strategic Update to February 13 - StockTitan
SABBY MANAGEMENT, LLC Acquires Significant Stake in Applied DNA Sciences Inc - GuruFocus.com
Featured Company NewsApplied DNA Sciences Enters into CertainT Trademark License Agreement with Techmer PM - AccessWire
When Would Be The Best Time To Buy Applied Dna Sciences Inc (NASDAQ: APDN) Stock? - Stocks Register
Applied DNA Sciences Secures Landmark Approval for Revolutionary CAR T-Cell Therapy Trial in Czech Republic - StockTitan
Why US Futures Are Rising WednesdayCorvus Pharma (NASDAQ:CRVS), Applied DNA Sciences (NASDAQ:APDN) - Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot - CT Insider
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Applied DNA Sciences Inc. (APDN) reports earnings - Quartz
Applied DNA Sciences Pivots to Genetic Medicine Manufacturing, Plans Major Restructuring Amid Revenue Drop - StockTitan
Applied DNA Sciences Sets Q4 Earnings Date, to Update on Key Manufacturing Expansion - StockTitan
APDN stock plunges to 52-week low of $0.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low of $0.15 amid market challenges - Investing.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Decrease in Short Interest - Defense World
Analysts Predict How High Applied Dna Sciences Inc (APDN) Will Go. - Stocks Register
Applied DNA stock jumps amid U.S. government mpox update - MSN
1.51%
자본화:
|
볼륨(24시간):